Sorensen KK, Yazdanfard PDW, Zareini B, Wood-Kurland HK, et al. Sustained glucagon-like peptide-1 receptor agonist treatment improves glycemic control and reduces all-cause mortality compared to dipeptidyl peptidase-4 inhibitors: A real-world target trial emulation in type 2 diabetes. Diabetes Obes Metab 2026 Feb 25. doi: 10.1111/dom.70581.
PMID: 41741950